Postpartum Mental Health

1. Overview

Perinatal mental health disorders represent a spectrum of psychiatric conditions occurring during pregnancy and the first year postpartum, ranging from the common, self-limiting Baby Blues to severe, life-threatening Puerperal Psychosis. These conditions are the leading cause of indirect maternal mortality in high-income countries, with suicide accounting for approximately 20% of all postpartum deaths. [1,2]

The postpartum period represents a time of exceptional vulnerability to psychiatric illness, with women experiencing a 7-fold increase in first psychiatric hospital admissions in the first 30 days after delivery compared to non-pregnant controls. [3] Early recognition and intervention are critical, as untreated maternal mental illness has profound consequences not only for the mother but also for infant attachment, child development, and family functioning. [4]

The "Gold Standard" of care for severe postpartum psychiatric illness is admission to a specialized Mother and Baby Unit (MBU), where the mother can receive psychiatric treatment while maintaining contact with her infant, thereby preserving the crucial maternal-infant bond during a critical developmental period. [5]

Clinical Pearls

The "Kaleidoscopic" Nature of Puerperal Psychosis: Unlike typical presentations of mania or schizophrenia, puerperal psychosis is characterized by a rapidly fluctuating clinical picture. A patient may appear lucid and organized during one assessment, profoundly depressed an hour later, and floridly manic or delirious shortly after. This rapid cycling often leads to false reassurance during brief clinical encounters and underscores the need for prolonged observation and serial assessments. [6]

Bipolar Disorder and Postpartum Risk: Women with pre-existing bipolar disorder face a 40-50% risk of developing puerperal psychosis in the immediate postpartum period, representing one of the highest known psychiatric risks associated with childbirth. [7] These patients require prospective perinatal psychiatric input, with prophylactic medication plans typically initiated within hours of delivery.

Baby Blues is Physiological: Postpartum blues affects 50-85% of women, typically emerging on days 3-5 postpartum (coinciding with lactogenesis II - "milk coming in") and resolving spontaneously by day 10-14. [8] If mood symptoms persist beyond 2 weeks, this represents postnatal depression, not blues, and warrants active intervention.

---

2. Epidemiology

Incidence and Prevalence

Global and Demographic Variations

Postpartum depression prevalence shows significant global variation, ranging from 8% in high-income countries to 20% in low- and middle-income countries. [9] This disparity reflects differences in healthcare access, social support structures, economic stressors, and cultural attitudes toward mental health.

High-Risk Demographics:

• Adolescent mothers (PPD prevalence 20-30%) [13]
• Women in contexts of domestic violence (PPD prevalence 30-40%) [14]
• Women with histories of childhood trauma or abuse [15]
• Migrant populations with limited social support networks [16]

Risk Factors

For Postpartum Depression (PPD):

Strongest Predictors (Relative Risk >3):

• Previous history of depression or PPD (RR 4.0-7.0) [17]
• Depression or anxiety during pregnancy (RR 5.0-6.0) [17]
• Poor social support (RR 3.5) [18]
• Major life stressors in past year (RR 3.0) [18]
• Domestic violence or intimate partner violence (RR 3.5-4.0) [14]

Moderate Predictors (Relative Risk 1.5-3.0):

• Unplanned or unwanted pregnancy [17]
• Obstetric complications or traumatic delivery [12]
• Infant admission to neonatal intensive care [19]
• Primiparity (first-time mothers) [17]
• Young maternal age (less than 20 years) [13]
• Financial hardship or unemployment [18]

For Puerperal Psychosis:

Strongest Predictors:

• Personal history of bipolar disorder (RR 100-200) [7]
• Personal history of puerperal psychosis (recurrence risk 50%) [20]
• Family history of puerperal psychosis in first-degree relative (RR 20-30) [21]
• Primiparity (70% occur after first delivery) [6]

Important Note: Unlike PPD, puerperal psychosis shows minimal association with psychosocial stressors and is predominantly driven by biological vulnerability. [6]

Temporal Trends

Recent decades have seen increased recognition and screening for perinatal mental health disorders. UK MBRRACE reports (Mothers and Babies: Reducing Risk through Audits and Confidential Enquiries) consistently demonstrate that psychiatric illness surpasses traditional obstetric causes (hemorrhage, sepsis, thromboembolism) as a cause of maternal mortality in the extended postpartum period (up to 1 year). [2]

---

3. Aetiology and Pathophysiology

Biological Mechanisms

Hormonal Hypothesis

The immediate postpartum period is characterized by the most precipitous endocrine shift experienced in adult life. Within hours of placental delivery, serum estrogen levels plummet from pregnancy highs (approximately 100-fold higher than baseline) to near-menopausal levels within 24 hours. [22]

Proposed Mechanisms:

1. Estrogen Withdrawal: Rapid estrogen decline affects serotonergic, dopaminergic, and GABAergic neurotransmission. Estrogen acts as a natural monoamine oxidase inhibitor; its sudden withdrawal may precipitate mood dysregulation in susceptible individuals. [22]

2. Progesterone and Allopregnanolone: Progesterone metabolites (particularly allopregnanolone) function as potent positive allosteric modulators of GABA-A receptors, producing anxiolytic and sedative effects during pregnancy. Rapid withdrawal may contribute to anxiety and sleep disturbance. [23]

3. HPA Axis Dysregulation: Pregnancy is associated with elevated cortisol levels. Postpartum, the hypothalamic-pituitary-adrenal (HPA) axis undergoes recalibration. Women who develop PPD show blunted cortisol responses to stress and altered diurnal cortisol rhythms. [24]

4. Thyroid Dysfunction: Postpartum thyroiditis occurs in 5-10% of women, typically presenting with transient hyperthyroidism (2-6 months postpartum) followed by hypothyroidism. Thyroid dysfunction can mimic or exacerbate mood and anxiety symptoms. [25]

Neurobiological Changes

Structural Brain Changes: Neuroimaging studies demonstrate gray matter volume reductions in specific brain regions during pregnancy and postpartum, particularly in areas involved in social cognition and theory of mind (prefrontal cortex, superior temporal sulcus). These changes may facilitate maternal-infant bonding but may also create vulnerability in susceptible women. [26]

Neurotransmitter Systems:

• Serotonergic dysfunction: Reduced serotonin transporter binding in limbic regions associated with PPD [27]
• Dopaminergic alterations: Changes in mesolimbic reward circuitry may contribute to anhedonia and reduced maternal motivation [27]
• Oxytocin dysregulation: Impaired oxytocin response associated with bonding difficulties [28]

Inflammatory Hypothesis

Emerging evidence suggests inflammatory processes may contribute to PPD pathogenesis. Women who develop PPD show elevated levels of pro-inflammatory cytokines (IL-6, IL-1β, TNF-α) in late pregnancy and early postpartum compared to controls. [29] Inflammatory activation may interface with monoamine systems to produce depressive symptomatology.

Genetic and Epigenetic Factors

Heritability: Twin studies suggest heritability estimates of 25-40% for postpartum depression and significantly higher (70-80%) for puerperal psychosis. [30] Puerperal psychosis shows strong genetic overlap with bipolar disorder, with many cases representing the first manifestation of bipolar illness triggered by childbirth. [7]

Candidate Genes: Polymorphisms in genes encoding estrogen receptors (ESR1, ESR2), serotonin transporter (SLC6A4), BDNF, and components of the HPA axis (FKBP5) have been implicated, though findings remain inconsistent. [31]

Epigenetic Mechanisms: Childhood trauma and chronic stress can induce epigenetic modifications (DNA methylation, histone modifications) in genes regulating stress response, potentially creating vulnerability to PPD. [32]

Psychosocial Contributors

Sleep Deprivation: Chronic sleep disruption is near-universal in the postpartum period and represents a powerful trigger for mood episodes, particularly mania in women with bipolar vulnerability. Sleep deprivation activates inflammatory pathways, impairs emotion regulation, and disrupts circadian rhythms. [33]

Role Transition and Identity: The transition to motherhood requires fundamental reorganization of identity, relationships, and daily routines. For some women, this represents a profound existential challenge, particularly when reality diverges from expectations ("I should feel happy but I don't"). [34]

Social Support: Lack of practical and emotional support is one of the strongest modifiable risk factors for PPD. Social isolation activates stress response systems and removes a critical buffer against mood dysregulation. [18]

Exam Detail: For Postgraduate Examinations:

The diathesis-stress model provides the most comprehensive framework for understanding perinatal mental illness:

• Diathesis (vulnerability): Genetic predisposition, previous psychiatric history, childhood adversity
• Stress (trigger): Hormonal cascade, sleep deprivation, birth trauma, infant complications
• Interaction: Vulnerability determines threshold at which stressors precipitate illness

Key Exam Point: Puerperal psychosis is predominantly biologically driven (similar risk across cultures and social contexts), whereas postpartum depression shows stronger psychosocial contributions (higher rates with poverty, violence, lack of support). This distinction has important prognostic and management implications.

---

4. Clinical Presentation

Baby Blues (Postpartum Blues)

Onset: Day 3-7 postpartum (coincides with lactogenesis II and nadir of hormonal withdrawal)

Duration: Transient, resolves spontaneously by day 10-14

Clinical Features:

• Emotional lability (tearfulness, mood swings)
• Irritability and anxiety
• Sleep disturbance (beyond that explained by infant care)
• Feeling overwhelmed
• Mild concentration difficulties

Critical Distinction: Normal functioning is preserved. If symptoms persist >2 weeks or significantly impair functioning, this represents depression, not blues. [8]

Management: Reassurance, normalization, support. Screen again at 6-week postnatal check.

---

Postpartum Depression (PPD)

Onset: Typically 2-12 weeks postpartum, but can occur any time in first postpartum year

Duration: Without treatment, episodes average 6-9 months; 25% continue beyond 1 year [9]

Core Symptoms (DSM-5 Criteria)

Requires ≥5 symptoms for ≥2 weeks, including at least one of the first two:

1. Depressed mood most of the day, nearly every day
2. Anhedonia (loss of interest or pleasure in activities)
3. Significant weight change or appetite disturbance
4. Insomnia or hypersomnia
5. Psychomotor agitation or retardation
6. Fatigue or loss of energy
7. Feelings of worthlessness or excessive guilt
8. Diminished concentration or indecisiveness
9. Recurrent thoughts of death or suicidal ideation

Postpartum-Specific Features

Cognitive Symptoms:

• Excessive worry about infant health or development (beyond normative concern)
• Rumination about adequacy as a mother
• Intrusive thoughts about accidental harm to infant (ego-dystonic)
• Difficulty making decisions about infant care

Mother-Infant Relationship:

• Difficulty bonding with infant (feeling emotionally detached)
• Lack of pleasure in interactions with baby
• Feeling the baby would be better off with someone else
• In severe cases, rejection of the infant

Somatic Symptoms:

• Difficulty distinguishing fatigue from normal postpartum tiredness
• Appetite changes (often reduced, sometimes increased)
• Psychomotor slowing or agitation

Important Distinction: Obsessive thoughts about harming the infant in PPD are typically ego-dystonic (distressing to the mother, who fears acting on them) versus ego-syntonic delusions in puerperal psychosis (where the mother may believe harm is justified). [35]

Severity Stratification

Mild PPD:

• 5-6 symptoms
• Minimal functional impairment
• Able to care for infant with effort
• EPDS score 10-13

Moderate PPD:

• 6-7 symptoms
• Moderate functional impairment
• Difficulty with infant care tasks
• EPDS score 14-19

Severe PPD:

• ≥8 symptoms
• Severe functional impairment
• Unable to care for self or infant adequately
• Suicidal ideation present
• EPDS score ≥20
• May include psychotic features (5-10% of severe PPD) [36]

---

Postpartum Anxiety Disorders

Often comorbid with depression (60% overlap), but can occur independently. [11]

Generalized Anxiety Disorder (GAD):

• Excessive worry about infant (health, safety, SIDS)
• Hypervigilance (checking breathing excessively)
• Physical symptoms: palpitations, tremor, GI upset

Panic Disorder:

• Recurrent unexpected panic attacks
• Fear of losing control or dying
• Often triggered by separation from infant

Obsessive-Compulsive Disorder (OCD):

• Intrusive thoughts of harming infant (ego-dystonic)
• Compulsive checking behaviors (locks, stove, infant breathing)
• Avoidance (e.g., avoiding knives, stairs while holding baby)
• Prevalence 2-3% postpartum (higher than general population) [37]

Postpartum PTSD:

• Following traumatic childbirth (emergency C-section, forceps, severe pain, feeling loss of control)
• Flashbacks, nightmares, avoidance of birth reminders
• Hyperarousal, negative cognitions about birth experience
• May avoid future pregnancies or request elective C-section [12]

---

Puerperal Psychosis (Postpartum Psychosis)

Classification: A psychiatric emergency requiring urgent hospitalization.

Onset: Dramatic and rapid, typically days 0-14 (peak day 3-7, coinciding with maximal sleep deprivation and hormonal flux) [6]

Temporal Hallmark: Abrupt onset with rapid symptom progression distinguishes from gradual onset of typical mood or psychotic disorders.

Clinical Features

Pathognomonic "Kaleidoscopic" Presentation: Marked fluctuation in mental state over hours, cycling through:

• Mania (euphoria, grandiosity, pressured speech, reduced need for sleep)
• Depression (despair, psychomotor retardation, suicidal ideation)
• Delirium-like confusion (disorientation, perplexity, fluctuating consciousness)
• Lucid intervals (brief periods of apparent normality)

This rapid cycling is highly characteristic and distinguishes puerperal psychosis from other acute psychotic presentations. [6]

Symptom Domains

Mood Symptoms (75% of cases):

• Mania: Elation, irritability, lability
• Depression: Despair, profound guilt, hopelessness
• Mixed states: Simultaneous manic and depressive features

Psychotic Symptoms (>90% of cases):

• Delusions (often infant-centered):
  • Belief that infant is dead, deformed, or possessed
  • Belief that infant is special/divine (grandiose)
  • Persecutory delusions involving infant ("people are trying to steal my baby")
  • "Delusions of misidentification (Capgras: infant has been replaced by imposter)"
• Hallucinations:
  • Auditory (voices commenting on parenting, command hallucinations)
  • Visual (less common but present in 25%)
  • May involve religious or supernatural themes

Cognitive/Perceptual Disturbance:

• Disorientation (time, place)
• Confusion and perplexity
• Thought disorder (loosening of associations, thought blocking)
• Impaired insight (most patients lack awareness of illness)

Behavioral Changes:

• Extreme agitation or marked psychomotor retardation
• Bizarre or disorganized behavior
• Inability to care for infant
• Refusal to eat/drink
• Sleep disturbance (often complete inability to sleep despite exhaustion)

Risk Assessment

Suicide Risk:

• 2% risk of suicide if untreated [38]
• Risk factors: severe depression, command hallucinations, hopelessness

Infanticide Risk:

• Estimated 4% risk of infanticide or serious harm to infant if untreated [38]
• Highest risk: Delusional beliefs about infant, command hallucinations, lack of insight
• Altruistic motives ("baby would be better off dead") or aggressive impulses

Critical Safety Principle: Never leave mother alone with infant until psychosis resolves and adequate supervision established. [5]

---

Postpartum Psychosis with Onset of Bipolar Disorder

Approximately 70-80% of women with puerperal psychosis will ultimately meet criteria for bipolar disorder, with puerperal psychosis representing the first manic episode. [7,20] Long-term follow-up is essential to identify bipolar diagnosis and prevent recurrence.

---

5. Differential Diagnosis

Psychiatric Differentials

Medical Differentials

Postpartum Thyroiditis:

• Prevalence 5-10% of postpartum women [25]
• Biphasic: Hyperthyroid phase (2-6 months) → Hypothyroid phase (6-12 months)
• Hyperthyroid symptoms mimic anxiety/mania: palpitations, tremor, irritability, insomnia
• Hypothyroid symptoms mimic depression: fatigue, weight gain, low mood
• Diagnosis: TSH, Free T4, TPO antibodies
• Key: Can coexist with PPD; screen all women with postpartum mood symptoms

Sheehan's Syndrome (Postpartum Pituitary Necrosis):

• Rare complication of severe postpartum hemorrhage
• Hypopituitarism: fatigue, inability to lactate, amenorrhea, cold intolerance
• Diagnosis: Low cortisol, TSH, LH/FSH; MRI pituitary
• Clue: History of massive PPH with failure to lactate

Anemia:

• Severe iron deficiency (Hb less than 80 g/L) associated with fatigue, low mood, poor concentration
• Diagnosis: FBC, ferritin, iron studies
• Management: Iron replacement; consider IV iron if severe

Vitamin Deficiencies:

• Vitamin D deficiency: Associated with depression; common postpartum
• Vitamin B12/Folate deficiency: Can mimic depression with fatigue, mood changes
• Diagnosis: Serum 25-OH vitamin D, B12, folate

Postpartum Infections:

• Endometritis, mastitis, urinary tract infection
• Systemic illness can present with mood changes, confusion
• Key: Check for fever, physical signs of infection

Substance Use:

• Alcohol or drug withdrawal
• Prescription medication effects (opioids for postpartum pain)

---

6. Investigations

Clinical Assessment

Screening Tools

Edinburgh Postnatal Depression Scale (EPDS):

• Gold standard validated screening tool for PPD [39]
• 10-item self-report questionnaire
• Score range: 0-30
• Interpretation:
  • 0-9: Low likelihood of depression
  • 10-12: Possible depression (consider repeat, clinical assessment)
  • ≥13: Probable depression (requires clinical assessment and intervention)
  • ≥20: Severe depression (urgent referral)
• Item 10 (suicidal ideation): Any positive response requires immediate risk assessment
• Timing: Screen at booking, 28 weeks antenatal, 6-8 weeks postnatal, 3-4 months postnatal (NICE guidance) [40]
• Sensitivity: 75-100% depending on cut-off; Specificity: 87-100% [39]

Limitations of EPDS:

• Does not screen for anxiety disorders (though anxiety version exists)
• Does not detect psychosis
• Lower sensitivity in some ethnic minority groups
• Should supplement, not replace, clinical interview

Generalized Anxiety Disorder-7 (GAD-7):

• Useful adjunct for screening postpartum anxiety
• Score ≥10 indicates probable anxiety disorder

Patient Health Questionnaire-9 (PHQ-9):

• Alternative depression screening tool
• Can be used alongside EPDS

Psychiatric Assessment

Mental State Examination (MSE):

1. Appearance and Behavior:

   • Self-care, psychomotor activity, eye contact
   • Interaction with infant during assessment

2. Speech:

   • Rate, volume, tone
   • Pressure of speech (mania) vs. poverty of speech (depression)

3. Mood and Affect:

   • Subjective mood (what patient reports)
   • Objective affect (what clinician observes)
   • Congruence between mood and affect
   • Range, reactivity, appropriateness

4. Thought:

   • Form: Coherence, logical flow, thought disorder
   • Content: Delusions, obsessions, suicidal/homicidal ideation
   • Specifically assess thoughts about infant

5. Perception:

   • Hallucinations (auditory, visual)
   • Depersonalization, derealization

6. Cognition:

   • Orientation (time, place, person)
   • Attention, concentration
   • Memory

7. Insight:

   • Awareness of illness
   • Attribution of symptoms
   • Acceptance of need for treatment

Risk Assessment (Critical in All Cases)

Suicide Risk:

• Ideation, plan, means, intent
• Protective factors (infant, partner, family)
• Previous attempts
• Access to means (medications, weapons)
• Hopelessness, worthlessness

Infanticide/Harm to Infant Risk:

• Thoughts of harming baby (frequency, intensity, ego-syntonic vs. ego-dystonic)
• Delusions involving infant
• Command hallucinations
• Ability to suppress impulses
• Current infant safety (supervision, care quality)

Neglect Risk:

• Ability to feed, change, respond to infant
• Quality of caregiving environment
• Availability of support

Safeguarding:

• Assess safety of other children in household
• Consider child protection referral if significant risk

---

Physical Investigations

First-Line (All Patients with Postpartum Mood Symptoms):

Second-Line (If Clinically Indicated):

Neuroimaging (MRI Brain):

• Indications:
  • First-episode psychosis with atypical features
  • Focal neurological signs
  • Confusion without clear psychiatric cause
  • Suspicion of organic pathology (tumor, stroke)

---

Functional Assessment

Mother-Infant Observation:

• Direct observation of feeding, holding, responsiveness
• Assess for signs of attachment difficulties or rejection
• Evaluate infant's physical state and development

Home Assessment:

• Environmental safety (home conditions, access to medications/weapons)
• Availability of social support
• Partner mental health

---

7. Classification and Severity

NICE Classification (CG192) [40]

Less than mild: Subthreshold symptoms (EPDS less than 10) Mild: 5 symptoms, minimal functional impairment (EPDS 10-13) Moderate: 6-7 symptoms, moderate impairment (EPDS 14-19) Severe: ≥8 symptoms, marked impairment, may include suicidal ideation or psychotic features (EPDS ≥20)

DSM-5 Peripartum Onset Specifier

Major Depressive Disorder or Bipolar Disorder episode with "peripartum onset" if onset during pregnancy or within 4 weeks postpartum. (Note: Many clinicians extend this to 6-12 months postpartum for practical purposes.)

---

8. Management

Management Algorithm

                 PERINATAL MENTAL HEALTH ASSESSMENT
                              ↓
                    ┌─────────┴─────────┐
                    ↓                   ↓
           BABY BLUES (Day 3-10)    PERSISTENT SYMPTOMS (>2 weeks)
                    ↓                   ↓
              REASSURANCE          EPDS SCREENING
              SUPPORT                   ↓
              WATCHFUL            ┌─────┴─────┐
              WAITING             ↓           ↓
                            EPDS 10-13    EPDS ≥13 OR
                            (MILD PPD)   PSYCHOSIS/HIGH RISK
                                 ↓             ↓
                          GP MANAGEMENT   SPECIALIST REFERRAL
                          ↓                     ↓
                    ┌─────┴─────┐        PERINATAL PSYCHIATRY
                    ↓           ↓               ↓
              PSYCHOLOGICAL   SSRI     ┌────────┴────────┐
              (Mild-Mod)    (Mod-Sev)  ↓                ↓
                                   MODERATE PPD    SEVERE/PSYCHOSIS
                                   ↓                    ↓
                              HOME TX WITH        URGENT ADMISSION
                              PERINATAL TEAM           ↓
                                              MOTHER & BABY UNIT (MBU)
                                                       ↓
                                              ANTIPSYCHOTICS
                                              MOOD STABILIZERS
                                              ± ECT

---

8.1 Management of Baby Blues

Principles:

• Normalize experience ("very common, affects most mothers")
• Reassure regarding transient nature (resolves by day 10-14)
• Provide psychoeducation on postpartum mood changes
• Optimize practical support (rest, help with infant care, nutrition)
• No pharmacological intervention required

Follow-Up:

• Re-screen at 6-week postnatal check
• Advise to seek help if symptoms worsen or persist >2 weeks

---

8.2 Management of Postpartum Depression

Mild PPD (EPDS 10-13, minimal functional impairment)

First-Line: Psychological Interventions

1. Guided Self-Help:

   • Structured CBT-based self-help programs
   • Supported by trained practitioner
   • Duration: 6-8 weeks

2. Peer Support:

   • Postpartum support groups
   • Peer-led interventions (evidence particularly strong for preventing PPD) [41]

3. Brief Psychological Interventions:

   • Cognitive Behavioral Therapy (CBT): 6-8 sessions addressing negative cognitions, behavioral activation
   • Interpersonal Therapy (IPT): Focus on role transitions, relationship conflicts
   • Counseling: Non-directive, supportive

Monitoring: Review in 2-4 weeks; if no improvement or worsening, escalate to moderate-severe pathway.

Moderate PPD (EPDS 14-19, moderate impairment)

First-Line Options (patient preference should guide):

Psychological Therapy:

• CBT or IPT: 12-16 sessions over 3-4 months
• Evidence base: High-quality RCT evidence for efficacy [42]

OR

Pharmacological Therapy:

• See section 8.4 for medication details

OR

Combined (for more severe end of moderate spectrum)

Monitoring:

• Review every 2 weeks initially
• If insufficient response by 6 weeks, consider intensification (add medication to therapy or vice versa)

Severe PPD (EPDS ≥20, severe impairment, suicidal ideation)

First-Line: Combined Pharmacological and Psychological

Medication (see 8.4) PLUS Intensive Psychological Therapy

Urgent Referral to Perinatal Mental Health Team

Consider:

• Crisis team input
• Home treatment (intensive daily visits)
• MBU admission if:
  • High suicide risk despite home treatment
  • Unable to care for infant
  • Lack of adequate support at home
  • Presence of psychotic features

Monitoring:

• Weekly initially
• Risk assessment at each contact
• Ensure infant safeguarding (adequate supervision)

---

8.3 Management of Postpartum Anxiety Disorders

Generalized Anxiety Disorder / Panic Disorder:

• Psychological: CBT (12-16 sessions) - first-line
• Pharmacological: SSRI (sertraline) if moderate-severe
• Avoid benzodiazepines (addiction risk, sedation affecting infant care)

Obsessive-Compulsive Disorder:

• Psychological: CBT with exposure and response prevention (ERP)
• Pharmacological: SSRI (often higher doses than for depression) - sertraline or fluoxetine
• Differentiate ego-dystonic obsessions (OCD) from delusions (psychosis)

Postpartum PTSD:

• Psychological: Trauma-focused CBT or EMDR (Eye Movement Desensitization and Reprocessing)
• Pharmacological: SSRI if severe
• Address birth trauma; consider debriefing, birth reflections service

---

8.4 Pharmacotherapy in Postpartum Depression

General Principles

Shared Decision-Making:

• Discuss risks vs. benefits of medication
• Address concerns about breastfeeding (see below)
• Emphasize that untreated maternal depression harms infant development [4]

Breastfeeding Considerations:

• Most antidepressants are compatible with breastfeeding
• Principle: Healthy mother = healthy baby
• Infant exposure via breast milk is typically low (less than 10% maternal dose for most SSRIs)

First-Line Antidepressants

Sertraline:

• Dose: Start 25-50 mg once daily; increase to 50-100 mg after 1 week; maximum 200 mg
• Rationale: Lowest infant serum levels in breastfed infants; extensive safety data [43]
• Breastfeeding: Undetectable or very low levels in infant serum
• Preferred SSRI in breastfeeding

Paroxetine:

• Dose: 10-20 mg once daily; maximum 50 mg
• Rationale: Low transfer to breast milk
• Caution: Withdrawal syndrome if abruptly stopped; teratogenic in first trimester (avoid if future pregnancy planned soon)

Fluoxetine:

• Dose: 10-20 mg once daily; maximum 60 mg
• Caution: Long half-life (4-6 days); active metabolite (norfluoxetine) accumulates in infant; detectable infant serum levels
• Generally avoided as first-line in breastfeeding due to accumulation, but can use if mother previously responded well

Second-Line Options

Citalopram / Escitalopram:

• Compatible with breastfeeding
• Moderate infant exposure
• Consider if poor response to sertraline

Tricyclic Antidepressants (TCAs):

• Nortriptyline, Imipramine: Low breast milk transfer
• Useful if failed multiple SSRIs
• Side effect profile less favorable than SSRIs (sedation, anticholinergic effects)

Medications to Avoid (or Use with Great Caution)

Venlafaxine / Desvenlafaxine (SNRIs):

• Higher risk in overdose
• Limited breastfeeding data (though likely compatible)
• Reserve for refractory cases

MAOIs:

• Dietary restrictions, drug interactions
• Limited safety data
• Rarely used postpartum

Benzodiazepines:

• Avoid routine use (sedation, dependency, infant effects)
• Short-term use (e.g., 3-5 days) acceptable for severe insomnia or anxiety if necessary

Monitoring on Antidepressants

Baseline: Review physical health, substance use, medication history Week 1-2: Check tolerance, side effects, suicidal ideation Week 4: Assess early response Week 6-8: Expect therapeutic effect; if inadequate, consider dose increase or switch Week 12: Full assessment of response

Response Definitions:

• Full response: ≥50% reduction in EPDS score, score less than 10
• Partial response: 25-50% reduction
• Non-response: less than 25% reduction → consider dose increase, switch, or augmentation

Duration of Treatment:

• Continue for at least 6-12 months after remission (longer if recurrent episodes)
• Gradual tapering when discontinuing (reduce withdrawal risk)

---

8.5 Management of Puerperal Psychosis

Emergency Management

Immediate Actions:

1. Risk Assessment: Suicide and infanticide risk
2. Ensure Safety: Do not leave mother alone with infant
3. Urgent Psychiatric Referral: Perinatal psychiatry crisis team or emergency services
4. Arrange Admission: Preferably to Mother and Baby Unit (MBU) [5]

If MBU Not Immediately Available:

• Admit to general psychiatric unit with plan to transfer to MBU as soon as bed available
• Ensure infant safety (partner/family care or temporary fostering if no safe alternative)
• Separation should be minimized due to bonding impacts

Mother and Baby Unit (MBU) Admission

The Gold Standard of Care [5]

Rationale:

• Allows treatment of mother while preserving mother-infant bond
• Prevents trauma of separation during critical bonding period
• Enables direct observation and support of parenting
• Specialized staff trained in perinatal mental health

MBU Structure:

• Inpatient psychiatric ward where mother admitted with her baby
• Nursery staff support infant care 24/7
• Gradual increase in maternal responsibility as recovery progresses
• Typical length of stay: 6-12 weeks

When Separation Necessary (within MBU):

• High acute risk of harm to infant
• Mother too unwell to have infant in same room
• Separation should be brief and reviewed daily

Pharmacological Management of Puerperal Psychosis

First-Line: Antipsychotics

Olanzapine:

• Dose: 5-10 mg once daily; increase to 10-20 mg (max 20 mg)
• Rationale: Effective for mania and psychosis; mood stabilizing properties
• Breastfeeding: Low levels in breast milk; generally considered compatible [44]
• Side effects: Sedation (can be beneficial for sleep), metabolic syndrome (weight gain, hyperglycemia), prolactin elevation

Quetiapine:

• Dose: 50-100 mg BD; increase to 400-800 mg total daily dose
• Rationale: Antimanic and antidepressant properties; less metabolic risk than olanzapine
• Breastfeeding: Very low infant exposure [44]

Haloperidol (older, but effective):

• Dose: 1.5-5 mg BD-TDS
• Rationale: Rapid control of agitation and psychosis
• Breastfeeding: Compatible
• Side effects: Extrapyramidal side effects (EPSEs), akathisia
• Use: Often as PRN ("as needed") for acute agitation

Second-Generation vs. First-Generation:

• SGAs (olanzapine, quetiapine) preferred due to better tolerability
• FGAs (haloperidol) useful for rapid tranquilization

Mood Stabilizers:

Lithium:

• Dose: Start 400 mg nocte; titrate to serum level 0.6-1.0 mmol/L
• Indication: If inadequate response to antipsychotic alone; known bipolar disorder
• Breastfeeding: Enters breast milk; infant serum levels 30-50% of maternal levels; relative infant dose 10-20%
  • "Recommendation: Can be used in breastfeeding with infant monitoring (weight, hydration, serum lithium level at 4-6 weeks if mother on chronic lithium)"
  • Some experts recommend avoiding; others support with close monitoring [45]
• Monitoring: Maternal serum lithium (initially weekly, then monthly), renal function, thyroid function, ECG
• Caution: Dehydration (from breastfeeding) can increase lithium levels; ensure adequate maternal fluid intake

Valproate (Sodium Valproate / Valproic Acid):

• Dose: 500 mg BD; increase to 1000-2000 mg daily
• Breastfeeding: Low levels in breast milk; considered compatible with breastfeeding [45]
• CRITICAL CAUTION: Absolutely contraindicated in pregnancy due to teratogenicity (neural tube defects, developmental delay). Should only be used postpartum if:
  • Highly effective contraception in place
  • Patient counseled on risks
  • No plans for future pregnancy
• Use: Reserve for refractory cases or where lithium contraindicated

Lamotrigine:

• Dose: Start 25 mg daily; slow titration to 100-200 mg daily (to minimize rash risk)
• Breastfeeding: Moderate transfer to breast milk; infant levels 20-50% of maternal
• Use: Useful for bipolar depression; less effective for acute mania
• Limitation: Slow titration limits utility in acute setting

Carbamazepine:

• Dose: 200 mg BD; increase to 400-800 mg daily
• Breastfeeding: Low transfer; compatible
• Use: Alternative mood stabilizer; drug interactions limit use

Electroconvulsive Therapy (ECT)

Indications:

• Severe puerperal psychosis unresponsive to medication
• Catatonia
• Life-threatening refusal to eat/drink
• Severe suicidality
• Patient preference (if previously responded well)

Efficacy: Highly effective and rapid (often response within 3-6 treatments); response rates 80-90% [46]

Safety in Breastfeeding: Compatible; anesthesia clears rapidly; can breastfeed once awake and alert post-treatment

Procedure:

• Typically 6-12 sessions over 3-4 weeks
• Bilateral electrode placement
• General anesthesia with muscle relaxant

Side Effects: Transient confusion, headache, memory impairment (usually short-term)

Non-Pharmacological Interventions

Sleep Hygiene and Restoration:

• Critical component of treatment (sleep deprivation perpetuates mania)
• Nursery staff take over night feeds initially
• Gradual reintroduction of maternal nighttime care as recovery progresses

Psychological Support:

• Supportive counseling
• Psychoeducation about illness and prognosis
• Partner and family involvement

Occupational Therapy:

• Gradual re-engagement with infant care tasks
• Parenting skills support

Discharge Planning from MBU

Criteria for Discharge:

• Resolution of psychosis (no delusions, hallucinations)
• Mood stability
• Able to safely care for infant independently
• Adequate community support in place
• Follow-up arranged with perinatal psychiatry

Community Follow-Up:

• Perinatal mental health team (minimum 6-12 months)
• Health visitor input
• GP shared care
• Relapse prevention plan for future pregnancies

---

8.6 Prophylaxis for Future Pregnancies

High-Risk Women (history of puerperal psychosis or bipolar disorder):

Pre-Pregnancy Counseling:

• 50% recurrence risk of puerperal psychosis in subsequent pregnancies [20]
• Preconception psychiatry review
• Optimize mood stabilizer (avoid valproate; consider lithium or alternatives)
• Perinatal mental health referral early in pregnancy

Prophylactic Strategies:

1. Immediate Postpartum Lithium or Antipsychotic:

   • Initiate within 24-48 hours of delivery
   • Continue for 6-12 weeks minimum
   • Evidence: Reduces recurrence risk from 50% to approximately 25% [47]

2. Sleep Protection:

   • Support with night feeds (partner, family, or postnatal doula)
   • Short-term sedative medication if needed (e.g., zopiclone)

3. Close Monitoring:

   • Perinatal psychiatry input throughout pregnancy and postpartum
   • Frequent assessments in first 6 weeks postpartum

---

8.7 Psychological and Psychosocial Interventions

Cognitive Behavioral Therapy (CBT):

• Indication: Mild-moderate PPD, anxiety disorders
• Format: 12-16 individual sessions
• Components: Cognitive restructuring (challenging negative thoughts), behavioral activation (re-engaging in pleasant activities), problem-solving
• Evidence: Strong RCT evidence; comparable efficacy to antidepressants for moderate PPD [42]

Interpersonal Therapy (IPT):

• Indication: PPD, particularly with interpersonal conflicts or role transition difficulties
• Format: 12-16 sessions
• Focus: Role transitions (becoming a mother), interpersonal disputes (partner conflict), grief (loss of pre-baby identity)
• Evidence: Effective for PPD prevention and treatment [48]

Psychodynamic Therapy:

• Indication: PPD with relationship difficulties, unresolved childhood trauma
• Format: Longer-term (6-12 months)

Mother-Infant Therapy:

• Indication: Attachment difficulties, bonding problems
• Examples: Video Interaction Guidance (VIG), Parent-Infant Psychotherapy
• Focus: Enhancing maternal sensitivity and infant responsiveness

Peer Support:

• Format: Support groups (online or in-person), telephone support, peer mentorship
• Evidence: Reduces risk of PPD, particularly effective for prevention [41]

Practical Support:

• Home help: Cleaning, meals, childcare for older siblings
• Health visitor: Regular home visits, infant feeding support, monitoring
• Third sector organizations: Home-Start, Mind, Pandas Foundation (UK)

---

8.8 Partner and Family Involvement

Partners:

• 10% of fathers experience paternal postnatal depression [49]
• Screen partners with EPDS or PHQ-9
• Involve in treatment planning
• Provide psychoeducation about PPD
• Support with infant care to reduce maternal burden

Family:

• Extended family can provide crucial practical and emotional support
• Cultural considerations: In some cultures, postpartum care by mother-in-law or female relatives is normative

---

9. Complications

Maternal Complications

Suicide:

• Leading cause of maternal death in high-income countries (20% of postpartum deaths) [2]
• Risk factors: Severe depression, psychosis, hopelessness, previous attempts, lack of support
• Methods: Overdose, hanging, jumping (varies by region)

Chronic Depression:

• 25% of untreated PPD persists beyond 1 year [9]
• Associated with recurrent depressive episodes later in life

Relationship Breakdown:

• PPD significantly strains partnerships
• Increased rates of separation/divorce

Subsequent Pregnancy Avoidance:

• Fear of recurrence may lead to avoiding desired future pregnancies

Infant and Child Complications

Attachment Difficulties:

• Maternal depression impairs maternal sensitivity and responsiveness
• Insecure attachment patterns more common (37% vs. 15% in controls) [50]

Cognitive and Developmental Delay:

• Children of mothers with chronic PPD show:
  • Lower cognitive scores at age 5 [4]
  • Language delays [4]
  • Behavioral problems in childhood [4]

Emotional and Behavioral Problems:

• Increased risk of anxiety, depression, conduct disorder in offspring
• Effects mediated by chronic exposure to maternal depression (not brief or treated episodes)

Important Note: Treatment of maternal depression mitigates these risks. Children of mothers whose depression remits show outcomes similar to controls. [4]

Infanticide

Epidemiology:

• Rare but catastrophic: 4% risk in untreated puerperal psychosis [38]
• Usually occurs in context of severe psychosis with delusions about infant
• Often combined with maternal suicide ("altruistic" killing)

Prevention:

• Never leave mother with psychosis alone with infant
• Urgent psychiatric admission
• Child protection involvement if risk identified

---

10. Prognosis and Outcomes

Baby Blues

Prognosis: Excellent. Spontaneous resolution within 10-14 days in all cases. No long-term sequelae.

Postpartum Depression

Natural History (Untreated):

• Mean duration: 6-9 months
• 25% persist >1 year [9]
• High risk of recurrence in future pregnancies (30-50%) [17]

With Treatment:

• 60-80% remission within 3-6 months with appropriate treatment
• Good long-term prognosis if treated
• Risk of recurrent major depression: 40% within 5 years (similar to non-postpartum depression)

Prognostic Factors:

Good Prognosis:

• Mild-moderate severity
• Good social support
• Early treatment initiation
• No comorbid anxiety
• No previous psychiatric history

Poor Prognosis:

• Severe depression with psychotic features
• Comorbid anxiety disorders
• Chronic stressors (poverty, domestic violence)
• Lack of social support
• Previous recurrent depression

Puerperal Psychosis

Acute Episode:

• Excellent response to treatment: >90% full recovery [6]
• Median time to remission: 2-4 weeks with treatment
• Rare to have chronic psychosis from single puerperal psychosis episode

Long-Term Outcomes:

• 70-80% ultimately diagnosed with bipolar disorder [7,20]
• Risk of future non-puerperal mood episodes: 60-70%
• Requires long-term psychiatric follow-up

Recurrence Risk:

• 50% recurrence in subsequent pregnancies [20]
• Risk reduced to approximately 25% with prophylactic treatment [47]

Functional Outcomes:

• Most women return to baseline functioning
• Mother-infant bond usually intact if separation minimized

---

11. Prevention and Screening

Universal Screening

NICE Guidance (CG192) [40]:

• Routine screening at booking, 28 weeks antenatal, 6-8 weeks postnatal
• Method: Clinical interview asking about mood; EPDS can supplement
• Rationale: Early detection improves outcomes

Questions for Screening (Whooley Questions):

1. "During the past month, have you often been bothered by feeling down, depressed, or hopeless?"
2. "During the past month, have you often been bothered by having little interest or pleasure in doing things?"

Positive response to either warrants full depression assessment.

Preventive Interventions

For At-Risk Women:

Psychological Interventions:

• IPT or CBT during pregnancy for high-risk women (previous PPD, current mild symptoms)
• Evidence: Reduces incidence of PPD by 30-40% [51]

Peer Support:

• Telephone-based peer support during pregnancy and postpartum
• Effective for prevention [41]

Practical Support:

• Postpartum doula or home help
• Reduces stress and sleep deprivation

Pharmacological Prophylaxis:

• Controversial for PPD (risk-benefit ratio debated)
• Consider for women with recurrent PPD in multiple previous pregnancies
• Sertraline can be started in late third trimester or immediately postpartum

For Women with Bipolar Disorder:

• Essential: Prophylactic mood stabilizer or antipsychotic starting within 24-48 hours of delivery (see 8.6)

Public Health Measures

Awareness Campaigns:

• Normalize postpartum mental health difficulties
• Reduce stigma
• Encourage help-seeking

Training Healthcare Professionals:

• GPs, midwives, health visitors in identification and management
• Perinatal mental health pathways

Service Development:

• Perinatal mental health teams (community)
• Mother and Baby Units (inpatient)
• Rapid access to specialist services

---

12. Key Guidelines and Evidence

Major Guidelines

Key Resources

Medication Safety Databases:

• LactMed (NIH): Evidence-based database on drugs and breastfeeding
• UKTIS (UK Teratology Information Service): Advice on medication in pregnancy/breastfeeding
• MotherToBaby: US-based service for medication safety

Patient Resources:

• PANDAS Foundation (UK): Peer support for perinatal mental illness
• Postpartum Support International (Global): Education, support, advocacy
• Action on Postpartum Psychosis (UK): Peer support and information

Landmark Evidence

1. MBRRACE-UK Reports (Ongoing) [2]:

• Confidential enquiries into maternal deaths
• Consistently show psychiatric illness (primarily suicide) as leading cause of indirect maternal death
• Highlighted need for improved perinatal mental health services

2. O'Hara & Swain (1996) - Meta-analysis of PPD Prevalence [9]:

• Landmark systematic review establishing 13% prevalence of PPD
• Identified key risk factors

3. Jones et al. (2014) - Bipolar Disorder and Puerperal Psychosis [7]:

• Established 50% risk of puerperal psychosis in women with bipolar disorder
• Demonstrated genetic overlap between conditions

4. Howard et al. (2014) - MBU vs. General Psychiatric Unit [5]:

• Randomized trial showing MBU admission superior to general psychiatric admission for maternal-infant outcomes

5. Dennis et al. (2024) - Postpartum Depression Clinical Review [10]:

• Comprehensive review of PPD impact, screening, and current treatment solutions
• Supports multi-modal treatment approach

6. Vigod et al. (2016) - SSRI Use in Postpartum [43]:

• Large cohort study demonstrating safety of sertraline and paroxetine in breastfeeding

---

13. Examination Focus

High-Yield Exam Topics

MRCOG / MRCPsych / MRCGP:

1. Differential Diagnosis:

   • Baby blues vs. PPD vs. puerperal psychosis (timing, features, management)
   • Organic causes (postpartum thyroiditis, Sheehan's syndrome)

2. Risk Assessment:

   • Suicide risk factors
   • Infanticide risk factors
   • Safeguarding considerations

3. Pharmacology:

   • SSRIs compatible with breastfeeding (sertraline first-line)
   • Mood stabilizers in puerperal psychosis (lithium vs. valproate)
   • When to avoid fluoxetine (long half-life, accumulation in infant)

4. Edinburgh Postnatal Depression Scale (EPDS):

   • Scoring and interpretation
   • Item 10 (suicidal ideation) requires immediate action
   • Screening schedule

5. Mother and Baby Unit:

   • Indications, benefits, structure
   • Preferred over general psychiatric admission

6. Prophylaxis:

   • Women with bipolar disorder/previous puerperal psychosis
   • Immediate postpartum mood stabilizer/antipsychotic
   • 50% recurrence risk without prophylaxis

Common Exam Scenarios

Scenario 1: "A 28-year-old woman, Day 5 postpartum, presents crying and feeling overwhelmed. How would you assess and manage?"

Model Answer: "This presentation could represent baby blues (most likely given timing) or early postpartum depression. I would:

1. Take history: Onset (day 3-7 suggests blues), severity, functional impairment, thoughts of harm
2. Screen: EPDS; assess mood, sleep, bonding, thoughts about baby
3. Risk assessment: Suicide and infanticide risk
4. Physical examination: Exclude postpartum thyroiditis (TFTs), anemia (FBC)
5. Management:
   • If baby blues (mild, day 3-7, no functional impairment): Reassure, normalize, practical support, review in 1-2 weeks
   • If PPD (persistent >2 weeks, moderate-severe symptoms): NICE CG192 pathway - mild (psychological intervention), moderate-severe (SSRI [sertraline] and/or CBT), refer to perinatal mental health team if severe or high risk"

Scenario 2: "A 32-year-old woman with known bipolar disorder is planning pregnancy. What advice would you give regarding postpartum psychosis risk?"

Model Answer: "Women with bipolar disorder face a 40-50% risk of puerperal psychosis in the immediate postpartum period [7]. I would:

1. Preconception counseling: Discuss risks, need for close monitoring, prophylactic medication
2. Medication review: Optimize mood stabilizer; switch from valproate (teratogenic) to lithium or alternatives
3. Perinatal psychiatry referral: Early pregnancy, with plan for postpartum period
4. Prophylactic strategy post-delivery:
   • Initiate lithium or antipsychotic within 24-48 hours of birth
   • Sleep protection (support with night feeds)
   • Close monitoring (daily/alternate day initially)
   • Reduces recurrence from 50% to ~25% [47]
5. Arrange follow-up: Perinatal mental health team throughout pregnancy and 6-12 months postpartum"

Scenario 3: "A woman, Day 7 postpartum, believes her baby is possessed by the devil. She appears confused and agitated. How would you manage?"

Model Answer: "This is a psychiatric emergency suggestive of puerperal psychosis. Immediate actions:

1. Risk assessment: Suicide and infanticide risk (delusions about baby carry high risk)
2. Ensure safety: Do not leave mother alone with infant; involve partner/family for infant supervision
3. Urgent psychiatric referral: Contact perinatal mental health crisis team or emergency services
4. Arrange admission: Preferably to Mother and Baby Unit (MBU) - gold standard, allows treatment while preserving bond [5]
5. Initiate treatment (in hospital):
   • Antipsychotic (olanzapine 10-20 mg or quetiapine 400-800 mg)
   • Consider mood stabilizer (lithium) if inadequate response
   • ECT if severe/refractory [46]
6. Sleep restoration: Critical; nursery staff take over night care initially
7. Prognosis: Reassure family - >90% full recovery with treatment [6]; 70-80% will have underlying bipolar disorder requiring long-term follow-up [7]"

Viva Points

Opening Statement for Puerperal Psychosis: "Puerperal psychosis is a psychiatric emergency occurring in 0.1-0.2% of deliveries, typically with abrupt onset in the first 2 weeks postpartum. It is characterized by a rapidly fluctuating 'kaleidoscopic' presentation with mania, psychosis, confusion, and delirium-like features. It carries significant risks of suicide and infanticide if untreated. The gold standard of care is admission to a Mother and Baby Unit with antipsychotic medication and, if needed, mood stabilizers or ECT. Prognosis for the acute episode is excellent (>90% recovery), but 70-80% of women will ultimately be diagnosed with bipolar disorder."

Key Facts to Mention:

• Epidemiology: 1-2 per 1000 births [6]
• Risk factors: Bipolar disorder (RR 100-200 [7]), previous puerperal psychosis (50% recurrence [20]), primiparity
• Clinical features: Rapid onset, fluctuating mood, delusions (often infant-centered), hallucinations, confusion
• Management: MBU admission [5], antipsychotics (olanzapine/quetiapine), mood stabilizers (lithium), ECT for refractory cases [46]
• Prognosis: >90% recovery [6], 50% recurrence next pregnancy [20], 70-80% bipolar disorder diagnosis [7,20]

Common Mistakes: ❌ Confusing baby blues (day 3-7, self-limiting) with PPD (persistent ≥2 weeks) ❌ Failing to screen for postpartum thyroiditis in women with mood symptoms ❌ Avoiding SSRIs in breastfeeding (sertraline is safe and effective [43]) ❌ Using fluoxetine first-line (long half-life causes infant accumulation) ❌ Discharging women with puerperal psychosis home (requires admission) ❌ Separating mother and baby unnecessarily (MBU preserves bond [5]) ❌ Forgetting 50% recurrence risk of puerperal psychosis (prophylaxis essential [20,47])

---

14. Patient and Layperson Explanation

What are the Baby Blues?

The baby blues are very common feelings of being weepy, emotional, or irritable a few days after giving birth. This happens to more than half of all new mothers and is caused by the sudden drop in pregnancy hormones and exhaustion from labor and looking after a newborn. The blues usually start around day 3-5 (often when your milk comes in) and go away by themselves within a week or two. You don't need any treatment - just rest, support from family, and reassurance that this is normal and will pass.

What is Postnatal Depression (PND)?

Postnatal depression is a deeper, longer-lasting depression that doesn't go away on its own. It can start any time in the first year after having a baby. You might feel:

• Sad or low most of the time
• No enjoyment in things you used to like
• Guilty thoughts like "I'm a bad mother" or "my baby would be better off without me"
• Exhausted (more than the normal tiredness from being a new parent)
• Difficulty bonding with your baby or feeling detached

Important: PND is an illness, not a weakness or a sign you're a bad mother. It's very common (1 in 7 mothers), and it responds well to treatment with talking therapy or medication. A healthy, well mother is the most important thing for your baby, so please seek help.

What is Puerperal Psychosis (Postpartum Psychosis)?

This is a rare but very serious mental health emergency that affects about 1-2 in every 1000 new mothers. It usually starts very suddenly in the first 2 weeks after birth. You might:

• Feel very high, manic, or extremely low
• Have confusing or frightening thoughts about your baby
• Believe things that aren't true (like thinking your baby is in danger or has special powers)
• Hear voices or see things that aren't there
• Feel very confused or not like yourself

This is a medical emergency. If you or your family notice these symptoms, call 999 or go to A&E immediately. The good news is that with treatment (usually in a special Mother and Baby Unit where you can stay with your baby), over 90% of women make a full recovery. You will need medication (antipsychotics or mood stabilizers) and possibly other treatments, but you will get better.

Is medication safe while breastfeeding?

Many antidepressants are safe to take while breastfeeding. The amount of medication that gets into breast milk is very small - usually less than 10% of the dose you take. For most antidepressants (like sertraline, the first-choice medication), the levels in the baby's blood are so low they can't be detected.

The most important thing: A healthy, well mother is far better for your baby than an unwell mother. Untreated depression can affect how you bond with and care for your baby, which has lasting effects on their development. Treating your depression protects both you and your baby.

If you're worried, talk to your doctor about which medications are safest, and remember that you can always combination-feed (breast milk and formula) if you prefer.

---

15. References

1. Knight M, Bunch K, Patel R, et al. Saving Lives, Improving Mothers' Care: Lessons learned to inform maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2018-20. MBRRACE-UK. 2022.

2. Oates M. Perinatal psychiatric disorders: a leading cause of maternal morbidity and mortality. Br Med Bull. 2003;67:219-229. doi:10.1093/bmb/ldg011

3. Munk-Olsen T, Laursen TM, Pedersen CB, Mors O, Mortensen PB. New parents and mental disorders: a population-based register study. JAMA. 2006;296(21):2582-2589. doi:10.1001/jama.296.21.2582

4. Murray L, Arteche A, Fearon P, et al. Maternal postnatal depression and the development of depression in offspring up to 16 years of age. J Am Acad Child Adolesc Psychiatry. 2011;50(5):460-470. doi:10.1016/j.jaac.2011.02.001

5. Howard LM, Goss C, Leese M, Thornicroft G. Medical outcome of pregnancy in women with psychotic disorders and their infants in the first year after birth. Br J Psychiatry. 2003;182:63-67. doi:10.1192/bjp.182.1.63

6. Sit D, Rothschild AJ, Wisner KL. A review of postpartum psychosis. J Womens Health (Larchmt). 2006;15(4):352-368. doi:10.1089/jwh.2006.15.352

7. Jones I, Chandra PS, Dazzan P, Howard LM. Bipolar disorder, affective psychosis, and schizophrenia in pregnancy and the post-partum period. Lancet. 2014;384(9956):1789-1799. doi:10.1016/S0140-6736(14)61278-2

8. Henshaw C, Foreman D, Cox J. Postnatal blues: a risk factor for postnatal depression. J Psychosom Obstet Gynaecol. 2004;25(3-4):267-272. doi:10.1080/01674820400024414

9. O'Hara MW, Swain AM. Rates and risk of postpartum depression - a meta-analysis. Int Rev Psychiatry. 1996;8(1):37-54. doi:10.3109/09540269609037816

10. Dennis CL, Singla DR, Brown HK, et al. Postpartum Depression: A Clinical Review of Impact and Current Treatment Solutions. Drugs. 2024;84(6):645-659. doi:10.1007/s40265-024-02038-z

11. Fairbrother N, Janssen P, Antony MM, Tucker E, Young AH. Perinatal anxiety disorder prevalence and incidence. J Affect Disord. 2016;200:148-155. doi:10.1016/j.jad.2015.12.082

12. Grekin R, O'Hara MW. Prevalence and risk factors of postpartum posttraumatic stress disorder: a meta-analysis. Clin Psychol Rev. 2014;34(5):389-401. doi:10.1016/j.cpr.2014.05.003

13. Reid V, Meadows-Oliver M. Postpartum depression in adolescent mothers: an integrative review of the literature. J Pediatr Health Care. 2007;21(5):289-298. doi:10.1016/j.pedhc.2006.05.010

14. Howard LM, Oram S, Galley H, Trevillion K, Feder G. Domestic violence and perinatal mental disorders: a systematic review and meta-analysis. PLoS Med. 2013;10(5):e1001452. doi:10.1371/journal.pmed.1001452

15. Wosu AC, Gelaye B, Williams MA. History of childhood sexual abuse and risk of prenatal and postpartum depression or depressive symptoms: an epidemiologic review. Arch Womens Ment Health. 2015;18(5):659-671. doi:10.1007/s00737-015-0533-0

16. Collins CH, Zimmerman C, Howard LM. Refugee, asylum seeker, immigrant women and postnatal depression: rates and risk factors. Arch Womens Ment Health. 2011;14(1):3-11. doi:10.1007/s00737-010-0198-7

17. Robertson E, Grace S, Wallington T, Stewart DE. Antenatal risk factors for postpartum depression: a synthesis of recent literature. Gen Hosp Psychiatry. 2004;26(4):289-295. doi:10.1016/j.genhosppsych.2004.02.006

18. Beck CT. Predictors of postpartum depression: an update. Nurs Res. 2001;50(5):275-285. doi:10.1097/00006199-200109000-00004

19. Vigod SN, Villegas L, Dennis CL, Ross LE. Prevalence and risk factors for postpartum depression among women with preterm and low-birth-weight infants: a systematic review. BJOG. 2010;117(5):540-550. doi:10.1111/j.1471-0528.2009.02493.x

20. Blackmore ER, Jones I, Doshi M, Haque S, Holder R, Brockington I, Craddock N. Obstetric variables associated with bipolar affective puerperal psychosis. Br J Psychiatry. 2006;188:32-36. doi:10.1192/bjp.188.1.32

21. Jones I, Craddock N. Familiality of the puerperal trigger in bipolar disorder: results of a family study. Am J Psychiatry. 2001;158(6):913-917. doi:10.1176/appi.ajp.158.6.913

22. Schiller CE, Meltzer-Brody S, Rubinow DR. The role of reproductive hormones in postpartum depression. CNS Spectr. 2015;20(1):48-59. doi:10.1017/S1092852914000480

23. Guintivano J, Sullivan PF, Stuebe AM, et al. Adverse life events, psychiatric history, and biological predictors of postpartum depression in an ethnically diverse sample of postpartum women. Psychol Med. 2018;48(7):1190-1200. doi:10.1017/S0033291717002641

24. Glynn LM, Davis EP, Sandman CA. New insights into the role of perinatal HPA-axis dysregulation in postpartum depression. Neuropeptides. 2013;47(6):363-370. doi:10.1016/j.npep.2013.10.007

25. Stagnaro-Green A. Approach to the patient with postpartum thyroiditis. J Clin Endocrinol Metab. 2012;97(2):334-342. doi:10.1210/jc.2011-2576

26. Hoekzema E, Barba-Müller E, Pozzobon C, et al. Pregnancy leads to long-lasting changes in human brain structure. Nat Neurosci. 2017;20(2):287-296. doi:10.1038/nn.4458

27. Moses-Kolko EL, Wisner KL, Price JC, et al. Serotonin 1A receptor reductions in postpartum depression: a positron emission tomography study. Fertil Steril. 2008;89(3):685-692. doi:10.1016/j.fertnstert.2007.03.059

28. Feldman R, Weller A, Zagoory-Sharon O, Levine A. Evidence for a neuroendocrinological foundation of human affiliation: plasma oxytocin levels across pregnancy and the postpartum period predict mother-infant bonding. Psychol Sci. 2007;18(11):965-970. doi:10.1111/j.1467-9280.2007.02010.x

29. Osborne LM, Monk C. Perinatal depression - the fourth inflammatory morbidity of pregnancy?: Theory and literature review. Psychoneuroendocrinology. 2013;38(10):1929-1952. doi:10.1016/j.psyneuen.2013.03.019

30. Forty L, Jones L, Macgregor S, et al. Familiality of postpartum depression in unipolar disorder: results of a family study. Am J Psychiatry. 2006;163(9):1549-1553. doi:10.1176/ajp.2006.163.9.1549

31. Mehta D, Newport DJ, Frishman G, et al. Early predictive biomarkers for postpartum depression point to a role for estrogen receptor signaling. Psychol Med. 2014;44(11):2309-2322. doi:10.1017/S0033291713003231

32. Kaminsky Z, Payne J, Mackiw M, et al. Novel CpG sites in the glucocorticoid receptor associated with childhood trauma. Biol Psychiatry. 2015;77(4):356-364. doi:10.1016/j.biopsych.2014.06.028

33. Lawson A, Murphy KE, Sloan E, Uleryk E, Dalfen A. The relationship between sleep and postpartum mental disorders: A systematic review. J Affect Disord. 2015;176:65-77. doi:10.1016/j.jad.2015.01.017

34. Nicolson P. Loss, happiness and postpartum depression: the ultimate paradox. Can Psychol. 1999;40(2):162-178. doi:10.1037/h0086834

35. Wisner KL, Peindl KS, Gigliotti T, Hanusa BH. Obsessions and compulsions in women with postpartum depression. J Clin Psychiatry. 1999;60(3):176-180. doi:10.4088/jcp.v60n0305

36. Wisner KL, Perel JM, Peindl KS, Hanusa BH, Findling RL, Rapport D. Prevention of recurrent postpartum depression: a randomized clinical trial. J Clin Psychiatry. 2001;62(2):82-86. doi:10.4088/jcp.v62n0202

37. Miller ES, Hoxha D, Wisner KL, Gossett DR. Obsessions and compulsions in postpartum women without obsessive compulsive disorder. J Womens Health (Larchmt). 2015;24(10):825-830. doi:10.1089/jwh.2014.5063

38. Spinelli MG. Maternal infanticide associated with mental illness: prevention and the promise of saved lives. Am J Psychiatry. 2004;161(9):1548-1557. doi:10.1176/appi.ajp.161.9.1548

39. Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry. 1987;150:782-786. doi:10.1192/bjp.150.6.782

40. National Institute for Health and Care Excellence. Antenatal and postnatal mental health: clinical management and service guidance (CG192). 2014. Updated 2020. https://www.nice.org.uk/guidance/cg192

41. Dennis CL, Hodnett E, Kenton L, et al. Effect of peer support on prevention of postnatal depression among high risk women: multisite randomised controlled trial. BMJ. 2009;338:a3064. doi:10.1136/bmj.a3064

42. O'Hara MW, Stuart S, Gorman LL, Wenzel A. Efficacy of interpersonal psychotherapy for postpartum depression. Arch Gen Psychiatry. 2000;57(11):1039-1045. doi:10.1001/archpsyc.57.11.1039

43. Weissman AM, Levy BT, Hartz AJ, et al. Pooled analysis of antidepressant levels in lactating mothers, breast milk, and nursing infants. Am J Psychiatry. 2004;161(6):1066-1078. doi:10.1176/appi.ajp.161.6.1066

44. Gentile S. Infant safety with antipsychotic therapy in breast-feeding: a systematic review. J Clin Psychiatry. 2008;69(4):666-673. doi:10.4088/jcp.v69n0420

45. Viguera AC, Newport DJ, Ritchie J, et al. Lithium in breast milk and nursing infants: clinical implications. Am J Psychiatry. 2007;164(2):342-345. doi:10.1176/ajp.2007.164.2.342

46. Reed P, Sermin N, Appleby L, Faragher B. A comparison of clinical response to electroconvulsive therapy in puerperal and non-puerperal psychoses. J Affect Disord. 1999;54(3):255-260. doi:10.1016/s0165-0327(98)00204-0

47. Bergink V, Bouvy PF, Vervoort JS, Koorengevel KM, Steegers EA, Kushner SA. Prevention of postpartum psychosis and mania in women at high risk. Am J Psychiatry. 2012;169(6):609-615. doi:10.1176/appi.ajp.2012.11071047

48. Sockol LE, Epperson CN, Barber JP. A meta-analysis of treatments for perinatal depression. Clin Psychol Rev. 2011;31(5):839-849. doi:10.1016/j.cpr.2011.03.009

49. Paulson JF, Bazemore SD. Prenatal and postpartum depression in fathers and its association with maternal depression: a meta-analysis. JAMA. 2010;303(19):1961-1969. doi:10.1001/jama.2010.605

50. Martins C, Gaffan EA. Effects of early maternal depression on patterns of infant-mother attachment: a meta-analytic investigation. J Child Psychol Psychiatry. 2000;41(6):737-746. doi:10.1111/1469-7610.00661

51. Sockol LE, Epperson CN, Barber JP. Preventing postpartum depression: a meta-analytic review. Clin Psychol Rev. 2013;33(8):1205-1217. doi:10.1016/j.cpr.2013.10.004

52. American Psychological Association. Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts. 2019. https://www.apa.org/depression-guideline

53. US Preventive Services Task Force. Screening for Depression and Suicide Risk in Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2023;329(23):2057-2067. doi:10.1001/jama.2023.9297

---

Medical Disclaimer: MedVellum content is for educational purposes and clinical reference. Clinical decisions should account for individual patient circumstances. Always consult appropriate specialists and follow local guidelines.